CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Regeneron Pharmaceuticals, Inc. et al. vs. Novartis Pharma AG et al.

Explore the PTAB proceeding IPR2021-00816 filed by Regeneron Pharmaceuticals, Inc. et al. on 2021-04-16. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2021-00816

Filing Date

2021-04-16

Accorded Filing Date

2021-04-16

Institution Decision Date

2021-10-26

Last Modified Date

2025-02-04

Proceeding Type

IPR

Termination Date

2022-10-25

Trial Status

Final Written Decision

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 13750352
Respondent Patent Number 9220631
Legal Expiration Date
2033-01-25 Active (6.2 yrs remaining)
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor Juergen Sigg et al
Respondent Tech Center TC 3700 - Mechanical Engineering & Manufacturing

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 3700 - Mechanical Engineering & Manufacturing

Decisions Rendered

3 Total

Proceeding Status

Final Written Decision

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (3)

Affirmed 2024-11-13
Other: Fed Circuit mandate
35 U.S.C. Trial Decision
Final Written Decision 2023-01-24
Final Written Decision: original
37 CFR 42.73, 35 USC 314, 35 USC 318
Institution Granted 2021-10-26
Institution Decision: Grant
35 USC 325, 35 USC 315, 35 USC 314, 37 CFR 42.71

Address and Attorney/Agent Information

32 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name NOVARTIS PHARMACEUTICAL CORPORATION - INTELLECTUAL PROPERTY DEPARTMENT
Customer Number 1095
Address 250 Massachusetts Avenue, Cambridge, MA, 02139, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
39030 Jean Silveri +1 617-871-5134
40232 Timothy Witkowski +1 617-301-1869
43228 Peter Waibel +1 862-778-7838
46473 Emily Wu +1 858-812-1539
46593 Laurie Lawrence +1 617-871-8584
48631 Carol Fang +1 650-467-2901
51681 Mark Flanigan +1 817-615-5080
53504 Daniel Raymond +1 858-812-1617

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 8 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts Counterparts in force
๐Ÿ›๏ธ
USPTO PTAB Trials 2 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (8): ๐Ÿ‡ฉ๐Ÿ‡ช Germany ๐Ÿ‡ช๐Ÿ‡บ Europe ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (2 found):
PTAB: 2
USPTO PTAB Trial 2020-07-16
IPR2020-01318

Regeneron Pharmaceuticals, Inc. et al. v. Novartis Pharma AG et al.

Asserted Patent
Status: Terminated
USPTO PTAB Trial 2020-07-16
IPR2020-01317

Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG et al.

Asserted Patent
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

200
123

Other: other court decision OTHER

2025-01-30 FILING PARTY: BOARD
121

Other: Fed Circuit mandate OTHER

2024-11-13 FILING PARTY: BOARD
122

Other: other court judgment OTHER

2024-11-13 FILING PARTY: BOARD
119

Final Written Decision: original FINAL

2023-01-24 FILING PARTY: BOARD
120

Order: Order: Granting Joint Motion to Seal ORDER

2023-01-24 FILING PARTY: BOARD

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc